L-Arginine supplementation enhanced expression of glucose transporter (GLUT 1) in sickle cell anaemia subjects in the steady state.
Autor: | Saka WA; Department of Physiology, Ladoke Akintola University of Technology, Ogbomosho, Nigeria., Anigbogu CN; Department of Physiology, College of Medicine, University of Lagos, Lagos, Nigeria., Kehinde MO; Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria., Jaja SI; Department of Physiology, College of Medicine, University of Lagos, Lagos, Nigeria. |
---|---|
Jazyk: | angličtina |
Zdroj: | Current research in physiology [Curr Res Physiol] 2022 Dec 06; Vol. 6, pp. 100096. Date of Electronic Publication: 2022 Dec 06 (Print Publication: 2023). |
DOI: | 10.1016/j.crphys.2022.11.003 |
Abstrakt: | L-Arginine may have therapeutic value in the management of sickle cell disease and diabetes mellitus. There is very little information on the interaction of GLUT 1 and L-Arginine in sickle cell disease subjects. This study compared the blood levels of Glut 1, fasting blood glucose (FBG) and fasting insulin (FIns) in non-sickle cell anaemia (HbAA) and sickle cell anaemia (HbSS) subjects in the steady state before and following L-Arginine supplementation (1 g/day for 6 weeks). Nitric oxide metabolites, (NO Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2022 Published by Elsevier B.V.) |
Databáze: | MEDLINE |
Externí odkaz: |